Mirum Pharmaceuticals (MIRM) Superinvestor holders
12 of the superinvestors we track hold Mirum Pharmaceuticals (MIRM) in their latest 13F filings, $325M in total.
Summary
The largest holder is Two Sigma (Two Sigma Investments), with $81M, 0.1% of the portfolio.
In their latest quarter: 1 opened a new position, 2 added, 9 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Two Sigma Two Sigma Investments |
Trimmed | 690,318 | $81M | 0.1% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 639,734 | $75M | 0.1% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 443,636 | $52M | 0.1% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 442,185 | $52M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 175,598 | $21M | 0.0% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 196,199 | $17M | 0.0% | Q3 2026 |
| Peter Muller PDT Partners |
Trimmed | 122,041 | $14M | 0.8% | Q2 2026 |
| Man Group Man Group plc |
New position | 37,183 | $4M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 28,647 | $3M | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 27,879 | $3M | 0.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
Added | 20,899 | $2M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 2,385 | $279,212 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 13 |
| Q1 2026 | 16 |
| Q4 2025 | 19 |
| Q3 2025 | 19 |
| Q2 2025 | 15 |
| Q1 2025 | 12 |
| Q4 2024 | 12 |
| Q3 2024 | 10 |
Questions about Mirum Pharmaceuticals
Which superinvestors own Mirum Pharmaceuticals?
12 of the superinvestors we track hold Mirum Pharmaceuticals (MIRM) in their latest 13F filings, $325M in total. Two Sigma, Hersh Cohen, Aziz Hamzaogullari, Jim Simons, Ensign Peak, Ken Fisher.
Who is the largest superinvestor holder of MIRM?
The largest holder is Two Sigma (Two Sigma Investments), with $81M, 0.1% of the portfolio.
From Mirum Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.